© 2020 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Negotiating better managed care contracts
October 20, 2020
Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.
What’s new on Dermatology Times: October 19-23
October 19, 2020
A glimpse at what to expect from Dermatology Times this week.
POLL: Have you ever experienced symptoms of imposter syndrome?
October 19, 2020
Selling your practice: The due diligence, legal documentation and final negotiation phases
October 19, 2020
Todd Petersen, CEO of VitalSkin Dermatology, covers the ins and outs of the due diligence, legal documentation and final negotiation stages of selling a practice.
Weekly Roundup: October 12-16
October 16, 2020
ICYMI, some of the content featured this week includes new 730 nm picosecond laser for benign pigmented lesions, managing patient volumes during the COVID-19 pandemic, tips on how to build your brand as a physician, plus more.
Phenotype-based approach advances management
October 16, 2020
The 21-member global ROSacea Consensus panel developed updated recommendations for rosacea, diagnosis, classification and management to support and promote transition to a phenotype approach in rosacea.
Misinformation delays rosacea diagnosis in skin of color patients
October 16, 2020
The idea that rosacea is uncommon in darker skinned individuals may be due to under-recognition. Careful clinical examination, a thorough history and biopsy in some cases are needed for accurate diagnosis and differentiating rosacea from diseases that may be more common.
The retinoid revolution
October 15, 2020
Zoe Diana Draelos, M.D., shares why retinoids can be found in many anti-aging formulations and how to reduce irritation from this potent antioxidant.
Managing pandemic patient volumes
October 15, 2020
Since the start of the pandemic, dermatologists have seen an average 50% drop in patient volume. While teledermatology has offered a channel for non-urgent patients and patient visits are rebounding, overall patient volumes are still significantly lower than 2019.
Tips for building your brand
October 15, 2020
In the final installment of this video series, Paige Velasquez Budde, CEO of Zilker Media, provides some useful tips for jump starting your brand as a physician.
I warned my patient – was it enough?
October 14, 2020
In this month’s Legal Eagle article, David J. Goldberg, M.D., J.D., discusses the different professional standards of disclosure that a physician must fulfill when treating patients.
Cysteamine cream, tranexamic acid mesotherapy reveal similar efficacy, different safety
October 14, 2020
Cysteamine cream and tranexamic acid mesotherapy demonstrated similar efficacy but yielded different safety results when being compared as a treatment for melasma, according to a recently published study.
Shaping your brand awareness
October 14, 2020
In part two of this video series, Paige Velasquez Budde, CEO of Zilker Media, reveals the benefits of shaping your brand awareness.
730 nm picosecond laser safe, effective for benign pigmented lesions
October 13, 2020
Lasers typically used for tattoo removal are on the rise as a possible treatment for melasma, with the novel 730 nm picosecond laser (PicoWay, Candela) being the most recently studied device which showed to be safe and effective for treating benign pigmented lesions.
What happened at ASDS?
October 13, 2020
Catch up on all of the latest news coming out of the 2020 American Society for Dermatologic Surgery (ASDS) virtual meeting.
Importance of building your brand as a physician
October 13, 2020
In this video interview, Paige Velasquez Budde, CEO of Zilker Media, explains the importance of building and shaping your brand as a physician.
The Mainstream Patient: October 12
October 12, 2020
This week’s edition of The Mainstream Patient features stories about a new toxic-free cosmetics bill in California, the benefits of benzoyl peroxide for acne, the legitimacy of collagen supplements, potential sunscreen changes by the FDA, plus more.
What’s new on Dermatology Times: October 12-16
October 12, 2020
A glimpse at what to expect from Dermatology Times this week.
POLL: Is climate change a rising issue within dermatology?
October 12, 2020
3D imaging technique measures severity of atrophic acne scars
October 11, 2020
There is a dire need to improve the clinical tools dermatologists use to assess the severity of acne scars. This 3D imaging technique may help, according to a recent study presented at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting.
Distinguishing scar from neoplasm using HF ultrasound
October 11, 2020
Dr. Jack Levy, chief resident in the Department of Dermatology at Emory University, discusses his recent presentation at the 2020 ASDS meeting about using high frequency ultrasound to distinguish scar tissue from neoplasm.
Diagnostic concordance lacking in poorly differentiated SCC
October 10, 2020
A recent study underscores the need for a consistent scale to grade risk levels of cutaneous squamous cell carcinoma (SCC), particularly poorly differentiated tumors, according to study authors who presented at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting.
Melanoma in situ: Imaging technique improves margin mapping
October 10, 2020
Performing reflectance confocal microscopy (RCM) with a mosaic technique before surgery can improve margin mapping in melanoma in situ (MIS), according to a recent study presented at 2020 ASDS Virtual Annual Meeting.
Weekly Roundup: October 5-9
October 09, 2020
ICYMI, some of the content featured this week includes articles about abobotulinumtoxinA injections for oily forehead, promising therapies for blastic plasmacytoid dendritic cell neoplasm (BPDCN), the benefits of CBD for the skin, plus more.
Nuances influence the neuromodulator decision
October 09, 2020
Experts share best practices for optimizing treatments using neuromodulators, assessing the next breakthrough products and avoiding complications at the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting.